Existing backer Novo has helped the teeth straightening technology producer close a series D round hiking its overall funding to over $170m.
US-based teeth straightening device maker InBrace closed a $102m series D round yesterday backed by Novo Ventures, the corporate venture capital arm of pharmaceutical firm Novo.
Investment firm Farallon Capital Management and asset manager Marshall Wace co-led the round, which also included Endeavour Vision, MVM Partners, RTW Investments, Soleus Capital, Vivo Capital, VenBio Partners and funds and accounts managed by BlackRock.
Founded in 2014 as Swift Health Systems, Inbrace has created a discreet teeth straightening system that uses computer modelling…
